Buy & Sell Enveric Biosciences Inc (ENVB) – Enveric Biosciences Inc Price Today
Aura AI Summary
Key Stats
- $8.43MMarket Cap
- HealthSector
- -60.34%3M Drawdown
- $3.52MEnterprise Value
- -Dividend Yield
- 91% Buy | 9% SellTrading Activity
- 4 daysTypical Hold Time
Enveric Biosciences Inc (ENVB) is currently valued at a market capitalization of $8.43M, with an enterprise value of $3.52M. Over the past 52 weeks, Enveric Biosciences Inc has traded between a low of $1.79 and a high of $17.4, highlighting its annual price range. Over the past three months, Enveric Biosciences Inc has recorded a drawdown of -60.34%, reflecting recent price volatility. On average, investors hold Enveric Biosciences Inc for approximately 4 days, indicating typical investor behavior on the platform.
About Enveric Biosciences Inc
Enveric Biosciences is a biotechnology company focused on developing next-generation psychedelic-inspired therapies for mental health and neuropsychiatric disorders.
Most Recent News
Universal Music Group rejects Pershing Square's undervalued buyout proposal, confident in growth strategy.
Universal Music Group's Board of Directors unanimously rejected an unsolicited buyout proposal from Pershing Square Capital Management, stating it undervalues the company and won't create superior value. The Board, supported by shareholders, highligh...

Broadcom gains billionaire investor as AI chip demand boosts stock and revenue forecasts.
Hedge fund billionaire Daniel Loeb increased his stake in Broadcom by buying 50,000 shares while reducing holdings in NVIDIA and Taiwan Semiconductor. Broadcom reported strong Q1 revenue of $19.31 billion, beating estimates, and expects Q2 revenue ar...

Dow Jones hits record 51,000 as Dell surges 28% on strong AI sales and outlook
U.S. stocks reached new highs with the Dow Jones Industrial Average topping 51,000, driven by a 28% surge in Dell Technologies shares after a strong Q1 report. Dell reported $43.8 billion in revenue, up 88% year-over-year, with $24.4 billion in AI-re...
